Stem cell therapy for Alport syndrome: the hope beyond the hype.
作者信息
Gross Oliver, Borza Dorin-Bogdan, Anders Hans-Joachim, Licht Christoph, Weber Manfred, Segerer Stephan, Torra Roser, Gubler Marie-Claire, Heidet Laurence, Harvey Scott, Cosgrove Dominic, Lees George, Kashtan Clifford, Gregory Martin, Savige Judy, Ding Jie, Thorner Paul, Abrahamson Dale R, Antignac Corinne, Tryggvason Karl, Hudson Billy, Miner Jeffrey H
机构信息
Department of Nephrology and Rheumatology, University Hospital Gottingen, Gottingen, Germany.
出版信息
Nephrol Dial Transplant. 2009 Mar;24(3):731-4. doi: 10.1093/ndt/gfn722. Epub 2008 Dec 25.
Abstract
摘要
相似文献
1
Stem cell therapy for Alport syndrome: the hope beyond the hype.用于奥尔波特综合征的干细胞疗法：超越炒作的希望。
Nephrol Dial Transplant. 2009 Mar;24(3):731-4. doi: 10.1093/ndt/gfn722. Epub 2008 Dec 25.
2
Could This Be Alport Syndrome?这会是奥尔波特综合征吗？
Clin J Am Soc Nephrol. 2021 Nov;16(11):1743-1745. doi: 10.2215/CJN.00120121. Epub 2021 Apr 13.
3
The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.阿尔波特综合征的发病机制涉及含α3（IV）链的IV型胶原分子：来自肾移植后抗肾小球基底膜肾炎的证据。
Kidney Int. 1992 Jul;42(1):179-87. doi: 10.1038/ki.1992.276.
4
Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.在患有Alport综合征的COL4A3基因敲除小鼠中，早期使用雷米普利治疗可延缓肾衰竭并减轻肾纤维化。
Kidney Int. 2003 Feb;63(2):438-46. doi: 10.1046/j.1523-1755.2003.00779.x.
5
Angiotensin-[1-7] attenuates kidney injury in experimental Alport syndrome.血管紧张素-[1-7]可减轻实验性 Alport 综合征的肾脏损伤。
Sci Rep. 2020 Mar 6;10(1):4225. doi: 10.1038/s41598-020-61250-5.
6
STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.STAT3 抑制可减轻 Alport 综合征小鼠模型的进行性表型。
Nephrol Dial Transplant. 2018 Feb 1;33(2):214-223. doi: 10.1093/ndt/gfx246.
7
Renal, auricular, and ocular outcomes of Alport syndrome and their current management.Alport 综合征的肾脏、耳部和眼部结局及其当前的治疗方法。
Pediatr Nephrol. 2018 Aug;33(8):1309-1316. doi: 10.1007/s00467-017-3784-3. Epub 2017 Sep 1.
8
Bull terrier hereditary nephritis: a model for autosomal dominant Alport syndrome.牛头梗遗传性肾炎：常染色体显性遗传性阿尔波特综合征的一个模型
Kidney Int. 1995 Mar;47(3):758-65. doi: 10.1038/ki.1995.116.
9
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.早期 PROTECT 遗传性肾炎试验中儿童的精确变异解读、表型确定以及基因型-表型相关性。
Clin Genet. 2021 Jan;99(1):143-156. doi: 10.1111/cge.13861. Epub 2020 Oct 25.
10
Familial hematuric syndromes--Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes.家族性血尿综合征——阿尔波特综合征、薄肾小球基底膜病以及费希特纳/爱泼斯坦综合征。
Contrib Nephrol. 2001(136):79-99. doi: 10.1159/000060181.
引用本文的文献
1
Spectrum of Alport syndrome in an Indian cohort.印度队列中Alport综合征的谱系
Pediatr Nephrol. 2025 Feb;40(2):393-405. doi: 10.1007/s00467-024-06507-1. Epub 2024 Sep 16.
2
Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.利用干细胞进行基因重编程可在 Alport 综合征中再生肾小球上皮足细胞。
Life Sci Alliance. 2024 Apr 1;7(6). doi: 10.26508/lsa.202402664. Print 2024 Jun.
3
Creation of X-linked Alport syndrome rat model with Col4a5 deficiency.建立 X 连锁 Alport 综合征大鼠模型 Col4a5 缺陷
Sci Rep. 2021 Oct 21;11(1):20836. doi: 10.1038/s41598-021-00354-y.
4
COL4A6 is dispensable for autosomal recessive Alport syndrome.COL4A6 对于常染色体隐性遗传性 Alport 综合征不是必需的。
Sci Rep. 2016 Jul 5;6:29450. doi: 10.1038/srep29450.
5
From Patient to Dish and Back Again: Are We There Yet?从患者到培养皿再回归：我们到了吗？
J Am Soc Nephrol. 2015 Aug;26(8):1757-9. doi: 10.1681/ASN.2014111158. Epub 2015 Jan 7.
6
The 2014International Workshop on Alport Syndrome.2014年奥尔波特综合征国际研讨会
Kidney Int. 2014 Oct;86(4):679-84. doi: 10.1038/ki.2014.229. Epub 2014 Jul 2.
7
A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.一种导致伴有异常胶原蛋白α3α4α5(IV)三聚体的奥尔波特肾小球硬化症的小鼠Col4a4突变。
Kidney Int. 2014 Jun;85(6):1461-8. doi: 10.1038/ki.2013.493. Epub 2014 Feb 12.
8
The regenerative potential of parietal epithelial cells in adult mice.成年小鼠顶泌上皮细胞的再生潜能。
J Am Soc Nephrol. 2014 Apr;25(4):693-705. doi: 10.1681/ASN.2013050481. Epub 2014 Jan 9.
9
Feasibility of repairing glomerular basement membrane defects in Alport syndrome.在 Alport 综合征中修复肾小球基底膜缺陷的可行性。
J Am Soc Nephrol. 2014 Apr;25(4):687-92. doi: 10.1681/ASN.2013070798. Epub 2013 Nov 21.
10
Danger control programs cause tissue injury and remodeling.危险控制程序会导致组织损伤和重塑。
Int J Mol Sci. 2013 May 28;14(6):11319-46. doi: 10.3390/ijms140611319.
本文引用的文献
1
Stem cell-based therapy for glomerular diseases: an evolving concept.基于干细胞的肾小球疾病治疗：一个不断发展的概念。
J Am Soc Nephrol. 2008 Sep;19(9):1621-3. doi: 10.1681/ASN.2008070735. Epub 2008 Aug 13.
2
Irradiation prolongs survival of Alport mice.辐射可延长奥尔波特综合征小鼠的生存期。
J Am Soc Nephrol. 2008 Sep;19(9):1692-700. doi: 10.1681/ASN.2007070829. Epub 2008 May 14.
3
Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.在阿尔波特综合征小鼠模型中，骨髓来源的细胞有助于足细胞再生和肾脏疾病的改善。
Stem Cells. 2006 Nov;24(11):2448-55. doi: 10.1634/stemcells.2006-0201. Epub 2006 Jul 27.
4
Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.肾小球基底膜中α3/α4（IV）型胶原蛋白的缺失会诱导一种应变依赖性的异构体转换为α5α6（IV）型胶原蛋白，这与Col4a3-/- Alport小鼠更长的肾脏存活时间相关。
J Am Soc Nephrol. 2006 Jul;17(7):1962-9. doi: 10.1681/ASN.2006020165. Epub 2006 Jun 12.
5
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.多能间充质干细胞可减轻胶原4A3缺陷小鼠的间质纤维化，但不会延缓慢性肾病的进展。
Kidney Int. 2006 Jul;70(1):121-9. doi: 10.1038/sj.ki.5001521. Epub 2006 May 24.
6
Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.骨髓源性干细胞修复基底膜胶原蛋白缺陷并逆转遗传性肾病。
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7321-6. doi: 10.1073/pnas.0601436103. Epub 2006 Apr 28.
7
Mouse model of X-linked Alport syndrome.X连锁遗传性肾炎的小鼠模型。
J Am Soc Nephrol. 2004 Jun;15(6):1466-74. doi: 10.1097/01.asn.0000130562.90255.8f.
8
Alport's syndrome, Goodpasture's syndrome, and type IV collagen.阿尔波特综合征、古德帕斯丘综合征与IV型胶原
N Engl J Med. 2003 Jun 19;348(25):2543-56. doi: 10.1056/NEJMra022296.
9
Determinants of vascular permeability in the kidney glomerulus.肾小球血管通透性的决定因素。
J Biol Chem. 2002 Aug 23;277(34):31154-62. doi: 10.1074/jbc.M204806200. Epub 2002 May 30.
10
Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.数量性状基因座影响奥尔波特综合征小鼠模型中的肾脏疾病进展。
Am J Pathol. 2002 Feb;160(2):721-30. doi: 10.1016/S0002-9440(10)64892-4.
Zotero 插件